BST-CarGel (TM) for cartilage repair
Canadian Coordinating Office for Health Technology Assessment
Record ID 32005000086
English, French
Authors' objectives:
To summarize the available information on the use of BST-CarGel (TM), manufactured by BioSyntech Inc. of Laval, Quebec, to regenerate articular cartilage (e.g. in the knee) and repair damage caused by osteoarthritis and sports injuries.
Authors' recommendations:
There is no safety or efficacy evidence from controlled trials of BST-CarGel (TM) for cartilage repair in humans. This technology may be best suited to younger candidates for total knee replacement who would likely need a subsequent knee replacement in 10 to 15 years.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
https://www.ccohta.ca/publications/pdf/152_No24_BSTCarGel_e.pdf
Year Published:
2004
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Athletic Injuries
- Cartilage, Articular
- Knee Joint
- Osteoarthritis
Contact
Organisation Name:
Canadian Coordinating Office for Health Technology Assessment
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.